Test conditions EPIDERMOSIL clinical trial - Cosmesi.it
Test conditions EPIDERMOSIL clinical trial - Cosmesi.it
Test conditions EPIDERMOSIL clinical trial - Cosmesi.it
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>EPIDERMOSIL</strong> <strong>clinical</strong> <strong>trial</strong><br />
use level<br />
5%<br />
<strong>Test</strong> <strong>cond<strong>it</strong>ions</strong><br />
35 women<br />
40-59 y.o.<br />
Twice a day<br />
on face
<strong>EPIDERMOSIL</strong> <strong>clinical</strong> <strong>trial</strong><br />
use level<br />
5%<br />
<strong>Test</strong> <strong>cond<strong>it</strong>ions</strong><br />
35 women<br />
40-59 y.o.<br />
Twice a day<br />
on face<br />
Product formulation:<br />
PHASE<br />
COMMERCIAL NAME<br />
INCI NAME<br />
%<br />
A<br />
POLYBASE CT<br />
CETEARYL ALCOHOL (and) POLYSORBATE 60<br />
10%<br />
POLYMOL CP<br />
CETYL PALMITATE<br />
2%<br />
B<br />
WATER<br />
WATER<br />
SQ 100<br />
C<br />
PHENOCHEM<br />
PHENOXYETHANOL<br />
1%<br />
<strong>EPIDERMOSIL</strong> SP<br />
HYALURONIC ACID (and) SILANETRIOL (and)<br />
WATER (and) METHYLPROPANEDIOL<br />
5%
<strong>EPIDERMOSIL</strong> <strong>clinical</strong> <strong>trial</strong><br />
use level<br />
5%<br />
<strong>Test</strong> <strong>cond<strong>it</strong>ions</strong><br />
35 women<br />
40-59 y.o.<br />
Twice a day<br />
on face<br />
Dermatologist assesment<br />
Subjects w<strong>it</strong>h improvements<br />
Average improvement<br />
Moisturizing<br />
Elastic<strong>it</strong>y<br />
Aging signs<br />
(fatigue, radiance…)<br />
Wrinkles<br />
Texture<br />
(relief homogene<strong>it</strong>y)<br />
General<br />
appearance<br />
97.1%<br />
94.1%<br />
87.1%<br />
90.3%<br />
100%<br />
100%<br />
37.5%<br />
14.3%<br />
7.4%<br />
13.3%<br />
36.4%<br />
36.4%
Volunteer n°10:<br />
T0<br />
T28<br />
<strong>EPIDERMOSIL</strong><br />
<strong>clinical</strong> <strong>trial</strong><br />
PRIMOS<br />
evaluation and<br />
images VISIA CR<br />
use level 5%<br />
Twice a day<br />
on face
<strong>EPIDERMOSIL</strong> <strong>clinical</strong> <strong>trial</strong><br />
use level<br />
5%<br />
<strong>Test</strong> <strong>cond<strong>it</strong>ions</strong><br />
35 women<br />
40-59 y.o.<br />
Twice a day<br />
on face<br />
Primos evaluation and<br />
images VISIA CR<br />
Volunteer n°23:<br />
Waviness Roughness Wrinkle depth<br />
Wrinkle<br />
reduction<br />
-30% -32% -17% -36%<br />
T0 T28<br />
T28 T0
Volunteer n°24:<br />
T0<br />
T28<br />
<strong>EPIDERMOSIL</strong><br />
<strong>clinical</strong> <strong>trial</strong><br />
PRIMOS<br />
evaluation and<br />
images VISIA CR<br />
use level 5%<br />
Twice a day<br />
on face
Volunteer n°35 Best performance<br />
massive wrinkles reduction and ovale lifting<br />
<strong>EPIDERMOSIL</strong><br />
<strong>clinical</strong> <strong>trial</strong><br />
PRIMOS<br />
evaluation and<br />
images VISIA CR<br />
use level 5%<br />
Twice a day<br />
on face
Change language